Last reviewed · How we verify
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma (SYGMA2)
The purpose of this study is to test if Symbicort (budesonide/formoterol) Turbuhaler is effective in treating asthma when used 'as needed' in patients with milder asthma. The efficacy of Symbicort 'as needed' will be compared with Pulmicort (budesonide) Turbuhaler twice daily plus terbutaline Turbuhaler 'as needed'
Details
| Lead sponsor | AstraZeneca |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 4215 |
| Start date | Fri Nov 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Aug 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Asthma
Interventions
- budesonide/formoterol 'as needed' + budesonide placebo bid
- budesonode bid + terbutaline 'as needed'
Countries
Colombia, Vietnam, Poland, South Korea, Philippines, New Zealand, Russia, Sweden, Mexico, Thailand, Bulgaria, France, South Africa, Slovakia, Chile, Saudi Arabia, Hungary, Romania, Brazil, Spain, Ukraine, Peru, Germany, Australia, Czechia